Expert Chaslau Koniukh
  • Companies
  • Global investment
  • Investors
  • Terminology
  • Economy
  • Stock Market
  • World exchanges
  • Tech and Marketing
Novo Nordisk
Stock Market

Danish company Novo Nordisk’s market valuation exceeds USD 500 billion

11.05.2024
2 min read

The reason behind Novo Nordisk’s success

Danish pharmaceutical company Novo Nordisk has reached a more than USD 500 billion valuation. This makes it the second company in the European Union to achieve this level of market capitalisation. It has even overtaken the LVMH group.
The pharmaceutical company owes its success to the worldwide popularity of two anti-obesity drugs:
– Wegovy – an anti-obesity drug;
– Ozempic – a weight loss drug for diabetics.
The drugs share the same active ingredient, which is why they have caused such a stir around the world.
Good sales figures have allowed analysts to make optimistic forecasts for 2024. Experts expect the company’s sales to grow by 26% and its operating profit by 29%.
The effectiveness of the obesity drugs Wegovy and Ozempic contributed to the record increase in demand. Unprepared for the hype, Nordisk is now actively ramping up production. For example, the company says it has more than doubled deliveries of Wegovy to the US. This will enable it to meet the demand for the drug from patients there.
However, experts are in no hurry to make long-term forecasts for Novo Nordisk. The company’s sales depend on two things:
– how the drug Zepbound, which Eli Lilly introduced in 2023, will perform;
– the length of time that people are on the drug for weight loss.
In addition, Wegovy has some properties that may affect its popularity. Adverse side effects include vomiting and diarrhoea. The cost of one month’s treatment is USD 1,349. These factors could lead to a rapid decline in the hype surrounding the drug. According to Bloomberg, the company’s shares could lose around 3% of their value over the next 12 months.Danish company Novo Nordisk

Novo Nordisk business overview

Novo Nordisk has been in business since 1923 as an insulin manufacturer. Despite its broad product range, the company focuses on diabetes medicines. It also produces hormone replacement therapy and growth hormones. The company has manufacturing facilities in nine countries and sells its products in 168 countries.
Novo Nordisk is the market leader in Denmark and the most valuable pharmaceutical company in the European Union. In 2023, its market capitalisation exceeded the GDP of its home country.
The effectiveness of Wegovy and Ozempic in treating obesity became known to a wide range of patients in 2022. Sales of these drugs soared to record levels and significantly contributed to the Danish economy. Around 60% of the country’s GDP came from the pharmaceutical sector. In the first six months of 2023, Novo Nordisk’s profits grew by 45%, reaching the USD 3.2 billion mark in the fourth quarter.

Tags: Stock Market
0
Previous Post How the UK financial sector is faring after Brexit Next Post Microsoft Azure Automation cloud platform can be used for crypto-mining

You Might Also Like

Microsoft shares
Stock Market
Microsoft shares up 65% in a year
09.04.2024
British startup
Stock Market
British startup Revolut is now available for users from Japan
08.05.2021
crypto hub in London
Stock Market
The British government wants to create a crypto hub in London
30.10.2022
LG dollar-denominated bonds
Stock Market
LG Electronics issues dollar-denominated bonds for the first time in 12 years
15.08.2024
Deposit rates in Russia
Stock Market
Deposit rates in Russia are losing their relevance as an option to generate income
21.05.2020
chinese stocks
Stock Market
Goldman Sachs: Chinese stocks show low risk
18.12.2022

Popular Posts

  • Li Ka Shing: How can success be achieved without money and education?
  • Skolkovo analysts: the Russian energy market is suffering losses
  • Ingeborg Mootz: a woman who became a stock player at the age of 75
  • Analysts: Egypt’s economy to continue falling in 2023

Editor's Picks

Chaslau Koniukh
Analytics

American bankers from JPMorgan and Goldman Sachs advise to invest in gold: review by Chaslau Koniukh.

Press Secretary
17.08.2020
Expert Chaslau Koniukh
Analytics

Chaslau Koniukh on the analysts’ opinion on the key stake size change soon

Press Secretary
18.06.2020
expert Chaslau Koniukh
Analytics

Chaslau Koniukh: Internet trade market in Russia may reach 2.78 trillion rubles.

Press Secretary
30.05.2020
Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh
Analytics

Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh

Press Secretary
16.05.2020

Popular Posts

  • Li Ka Shing: How can success be achieved without money and education?
  • Skolkovo analysts: the Russian energy market is suffering losses
  • Ingeborg Mootz: a woman who became a stock player at the age of 75
  • Analysts: Egypt’s economy to continue falling in 2023
  • Businessman Chuck Feeney: the man who gave the world Duty Free
Expert Chaslau Koniukh
  • Facebook
  • Twitter
  • Instagram

© 2024 CHASLAU KONIUKH. ALL RIGHTS RESERVED. Expert in marketing and project management, international investments, financial analyst.

Menu

  • Biography
  • Companies and corporations
  • Global investment
  • Investors and Entrepreneurs
  • Economy
  • Market terminology
  • Stock Market
  • World exchanges
  • Tech and Marketing
  • Analytics